Compare · LRCX vs MLAB
LRCX vs MLAB
Side-by-side comparison of Lam Research Corporation (LRCX) and Mesa Laboratories Inc. (MLAB): market cap, price performance, sector, and recent activity on the wire.
Summary
- LRCX operates in Technology, while MLAB operates in Industrials - the two are in different parts of the market.
- LRCX is the larger of the two at $391.80B, about 724.1x MLAB ($541.1M).
- LRCX has been more active in the news (5 items in the past 4 weeks vs 1 for MLAB).
- LRCX has more recent analyst coverage (25 ratings vs 3 for MLAB).
- Company
- Lam Research Corporation
- Mesa Laboratories Inc.
- Price
- -
- -
- Market cap
- $391.80B
- $541.1M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1984
- News (4w)
- 5
- 1
- Recent ratings
- 25
- 3
Lam Research Corporation
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
Mesa Laboratories Inc.
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment designs, manufactures, and markets quality control hardware and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. This segment's products include dialysate meters and calibration solutions, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company's Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Continuous Monitoring segment designs, develops, and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Latest LRCX
- The Hidden Layer of the AI Boom: Robotics, Packaging Equipment Companies Are Thriving
- Director Talwalkar Abhijit Y sold $6,124,470 worth of shares (18,282 units at $335.00) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 87,142 units (SEC Form 4)
- Lam Research Corporation Announces June Quarter Financial Conference Call
- President and CEO Archer Timothy exercised 30,000 shares at a strike of $30.03 and sold $11,700,300 worth of shares (30,000 units at $390.01) as part of a pre-agreed trading plan (SEC Form 4)
- Taiwan Semiconductor Suppliers Are Moving to the US, Creating New Opportunities
- SEC Form 11-K filed by Lam Research Corporation
- Director Brandt Eric sold $20,011,346 worth of shares (54,500 units at $367.18) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 144,705 units (SEC Form 4)
- Director Brandt Eric sold $19,118,360 worth of shares (54,500 units at $350.80) as part of a pre-agreed trading plan, decreasing direct ownership by 21% to 199,205 units (SEC Form 4)
- Senior Vice President Fernandes Neil J sold $2,371,226 worth of shares (7,659 units at $309.60) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 58,470 units (SEC Form 4)
- SEC Form SD filed by Lam Research Corporation
Latest MLAB
- MESA LABS DECLARES QUARTERLY DIVIDEND
- CAO Crennen Lyndsey Elizabeth sold $39,560 worth of shares (442 units at $89.50), exercised 726 shares at a strike of $95.10 and was granted 263 shares, increasing direct ownership by 37% to 2,020 units (SEC Form 4)
- SVP Operations Archbold Brian David exercised 3,324 shares at a strike of $95.10, was granted 1,859 shares and sold $225,187 worth of shares (2,516 units at $89.50), increasing direct ownership by 72% to 6,377 units (SEC Form 4)
- CFO Sakys John exercised 3,792 shares at a strike of $95.10, was granted 2,282 shares and sold $253,022 worth of shares (2,827 units at $89.50) as part of a pre-agreed trading plan, increasing direct ownership by 20% to 19,785 units (SEC Form 4)
- SVP Operations Archbold Brian David sold $116,558 worth of shares (1,151 units at $101.27), decreasing direct ownership by 24% to 3,710 units (SEC Form 4)
- CAO Crennen Lyndsey Elizabeth sold $11,950 worth of shares (118 units at $101.27), decreasing direct ownership by 7% to 1,473 units (SEC Form 4)
- CFO Sakys John sold $123,850 worth of shares (1,223 units at $101.27), decreasing direct ownership by 7% to 16,538 units (SEC Form 4)
- New insider Crennen Lyndsey Elizabeth claimed ownership of 1,863 shares (SEC Form 3)
- SVP Operations Archbold Brian David exercised 2,454 shares at a strike of $104.08, increasing direct ownership by 102% to 4,861 units (SEC Form 4)
- CFO Sakys John exercised 2,717 shares at a strike of $104.08, increasing direct ownership by 18% to 17,761 units (SEC Form 4)